SANDOZ 618 (Rivastigmine Tartrate 1.5 mg)
Pill with imprint SANDOZ 618 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sandoz Pharmaceuticals Inc..
Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANDOZ 618
Rivastigmine Tartrate
- Imprint:
- SANDOZ 618
- Strength:
- 1.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients:
- gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
More about rivastigmine
- Rivastigmine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 21 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
